Review Article | Published:

Megalin and cubilin: multifunctional endocytic receptors

Nature Reviews Molecular Cell Biology volume 3, pages 258268 (2002) | Download Citation



The ability to take up substances from the surrounding environment not only provides cells with vital nutrients, but also enables the selective transport of substances from one compartment to another. Megalin and cubilin are two structurally different endocytic receptors that interact to serve such functions. Evidence has accumulated in recent years to indicate that these receptors have important functions in both normal physiology and pathology.

Key points

  • Both megalin and cubilin are large, multiligand, endocytic-membrane glycoproteins. Megalin is a member of the low-density lipoprotein (LDL)-receptor family, which is composed of a large extracellular domain with several ligand-binding regions, a transmembrane domain and a short cytoplasmic tail with potential signal-activation sequences. Cubilin is a structurally very different peripheral membrane protein with no obvious transmembrane domain. The molecule is dominated by 27 CUB domains, which are involved in ligand binding.

  • Megalin and cubilin are expressed in epithelial cells of several tissues, including intestine, kidney, lung, brain, tissues involved in maternal-to-fetal exchange, endocrine glands, sense organs and the genital system.

  • Megalin and cubilin are involved in the endocytic uptake of many ligands, including lipoproteins, vitamin-binding proteins, other carrier proteins, hormones, enzymes and drugs in several epithelia. The receptors might work independently, but have also been shown to interact to facilitate the uptake of several ligands.

  • Megalin deficiency in mice is associated with multiorgan dysfunction and the syndrome of holoprosencephaly. Cubilin dysfunction in dogs or humans is associated with the syndrome of hereditary megaloblastic anaemia 1 and proteinuria.

  • Renal-tubular reabsorption and rescue of several filtered ligands, including hormones, vitamins and iron-carriers, is dependent on megalin and cubilin. In particular, the receptors are important for providing substrate for renal hydroxylation and activation of vitamin D.

  • Megalin might also have a further role in calcium regulation by serving as a calcium-sensing protein in the parathyroid gland and by mediating uptake and degradation of parathyroid hormone.

  • Megalin is involved in the regulation of thyroid-hormone production by the thyroid gland by mediating uptake and transcytosis of thyroglobulin.

  • The endocytic uptake of nephro- and ototoxic drugs, such as aminoglycosides, can be mediated by megalin, which indicates a role in the development of tissue damage caused by these agents.

  • Members of the LDL-receptor family can mediate intracellular signalling by binding of cytoplasmic adaptor proteins. Megalin has been shown to bind disabled protein 2, which indicates a role in signal transduction.

  • Future research is expected to resolve the specific functions of megalin and cubilin in fetal development, in vitamin homeostasis, and for the targeted uptake of steroid-carrier protein complexes in specific tissues. New perspectives might originate from the evolving concept of signalling by endocytic receptors.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    , , & Complete cloning and sequencing of rat gp330/'megalin', a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl Acad. Sci. USA 91, 9725–9729 (1994).This report described the full-length megalin sequence in rat.

  2. 2.

    et al. Cloning and sequencing of human gp330, a Ca2+-binding receptor with potential intracellular signaling properties. Eur. J. Biochem. 239, 132–137 (1996).

  3. 3.

    et al. Chromosomal localization of human genes for the LDL receptor family member glycoprotein 330 (LRP2) and its associated protein RAP (LRPAP1). Genomics 22, 88–93 (1994).

  4. 4.

    , , & Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science 244, 1163–1165 (1989).The partial cloning and first demonstration that megalin belongs to the LDLR family.

  5. 5.

    The low-density lipoprotein receptor gene family: multiple roles in lipid metabolism. J. Mol. Med. 77, 306–315 (1999).

  6. 6.

    Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family. Front Biosci. 6, D417–D428 (2001).

  7. 7.

    & A gene for a low density lipoprotein receptor-related protein in the nematode Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 90, 4572–4576 (1993).

  8. 8.

    et al. Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region. Nature 326, 760–765 (1987).

  9. 9.

    , & NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J. Biol. Chem. 265, 3116–3123 (1990).

  10. 10.

    , & Lipoprotein receptors: new roles for ancient proteins. Nature Cell Biol. 1, E157–E162 (1999).A review on the recently discovered functional aspects of lipoprotein receptors, including steroid hormone uptake and intracellular signalling.

  11. 11.

    et al. Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions. Proc. Natl Acad. Sci. USA 94, 2368–2373 (1997).

  12. 12.

    et al. Megalin-mediated endocytosis of transcobalamin–vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proc. Natl Acad. Sci. USA 93, 8612–8617 (1996).

  13. 13.

    , & Renal tubule gp330 is a calcium binding receptor for endocytic uptake of protein. J. Histochem. Cytochem. 40, 1481–1490 (1992).References 13, 115 and 128–130 simultaneously showed binding of RAP to megalin and established the protein as an endocytic receptor.

  14. 14.

    , , , & Identification of rat yolk sac target protein of teratogenic antibodies, gp280, as intrinsic factor-cobalamin receptor. J. Clin. Invest. 99, 2317–2322 (1997).The identification of cubilin as the intestinal intrinsic factor receptor, which established its role as an endocytic receptor.

  15. 15.

    et al. The intrinsic factor–vitamin B12 receptor and target of teratogenic antibodies is a megalin-binding peripheral membrane protein with homology to developmental proteins. J. Biol. Chem. 273, 5235–5242 (1998).This study described the full-length cubilin sequence in rat and identified the interaction between megalin and cubilin.

  16. 16.

    et al. The human intrinsic factor–vitamin B12 receptor, cubilin: molecular characterization and chromosomal mapping of the gene to 10p within the autosomal recessive megaloblastic anemia (MGA1) region. Blood 91, 3593–3600 (1998).

  17. 17.

    , , & Genetic evidence of an accessory activity required specifically for cubilin brush-border expression and intrinsic factor–cobalamin absorption. Blood 94, 3604–3606 (1999).The cloning of dog cubilin and linkage study using an inherited canine disorder that resembles the Imerslund–Gräsbecks syndrome.

  18. 18.

    & The CUB domain. A widespread module in developmentally regulated proteins. J. Mol. Biol. 231, 539–545 (1993).

  19. 19.

    et al. Molecular dissection of the intrinsic factor–vitamin B12 receptor, cubilin, discloses regions important for membrane association and ligand binding. J. Biol. Chem. 274, 20540–20544 (1999).This study, as well as reference 28, identifies ligand-binding regions and potential membrane-anchoring domains in cubilin.

  20. 20.

    & Interaction of model class A1, class A2, and class Y amphipathic helical peptides with membranes. Biochemistry 35, 11210–11220 (1996).

  21. 21.

    , & The amphipathic α-helices of the toxoplasma protein GRA2 mediate post-secretory membrane association. J. Cell Sci. 111, 2171–2180 (1998).

  22. 22.

    , , & The membrane association sequences of the prostaglandin endoperoxide synthases-1 and -2 isozymes. J. Biol. Chem. 273, 29830–29837 (1998).

  23. 23.

    , , , & The membrane association domain of RGS16 contains unique amphipathic features that are conserved in RGS4 and RGS5. J. Biol. Chem. 274, 19799–19806 (1999).

  24. 24.

    , , & RGS4 binds to membranes through an amphipathic α-helix. J. Biol. Chem. 275, 18520–18526 (2000).

  25. 25.

    , , & Effect of processing inhibitors on cobalamin (vitamin B12) transcytosis in polarized opossum kidney cells. Arch. Biochem. Biophys. 315, 8–15 (1994).

  26. 26.

    & Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia. Annu. Rev. Nutr. 21, 407–428 (2001).

  27. 27.

    et al. The intrinsic factor–vitamin B12 receptor, cubilin, is assembled into trimers via a coiled-coil α-helix. J. Biol. Chem. 274, 6374–6380 (1999).

  28. 28.

    , & Identification and characterization of two distinct ligand binding regions of cubilin. J. Biol. Chem. 276, 44777–44784 (2001).

  29. 29.

    et al. The crystal structures of two spermadhesins reveal the CUB domain fold. Nature Struct. Biol. 4, 783–788 (1997).

  30. 30.

    et al. The 2.4 Å resolution crystal structure of boar seminal plasma PSP-I/PSP-II: a zona pellucida-binding glycoprotein heterodimer of the spermadhesin family built by a CUB domain architecture. J. Mol. Biol. 274, 635–649 (1997).

  31. 31.

    , & Cubilin and megalin expression and their interaction in the rat intestine: effect of thyroidectomy. Am. J. Physiol. Endocrinol. Metab. 281, E900–E907 (2001).

  32. 32.

    et al. Characterization of an epithelial 460 kDa protein that facilitates endocytosis of intrinsic factor–vitamin B12 and binds receptor-associated protein. J. Biol. Chem. 272, 26497–26504 (1997).

  33. 33.

    , , & Immunocytochemical localization of the intrinsic factor–cobalamin receptor in dog-ileum: distribution of intracellular receptor during cell maturation. J. Cell Biol. 98, 1111–1118 (1984).

  34. 34.

    & The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc. Natl Acad. Sci. USA 79, 5557–5581 (1982).This paper establishes megalin as a pathogenic antigen of Heymann nephritis and localizes the protein to the endocytic apparatus.

  35. 35.

    et al. Characterization of a 280-kD protein restricted to the coated pits of the renal brush border and the epithelial cells of the yolk sac. Teratogenic effect of the specific monoclonal antibodies. J. Exp. Med. 167, 213–218 (1988).Identification of a 280-kDa coated pit glycoprotein (known later as cubilin) in kidney and yolk sac as the target of teratogenic antibodies.

  36. 36.

    , , & Purification, properties, and immunochemical localization of a receptor for intrinsic factor–cobalamin complex in the rat kidney. J. Biol. Chem. 263, 4443–4449 (1988).

  37. 37.

    , , , & Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. I. Renal distribution. Am. J. Pathol. 122, 500–511 (1986).

  38. 38.

    , & A large membrane glycoprotein (gp330) is a resident of coated pits of serveral absorptive epithelia. J. Cell Biol. Abstr. 98, 178a (1984).

  39. 39.

    , , , & Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. II. Extrarenal distribution. Am. J. Pathol. 122, 512–519 (1986).

  40. 40.

    et al. 500-kilodalton calcium sensor regulating cytoplasmic Ca2+ in cytotrophoblast cells of human placenta. J. Biol. Chem. 265, 8275–8279 (1990).

  41. 41.

    et al. Coexpression in humans by kidney and fetal envelopes of a 280 kDa-coated pit-restricted protein. Similarity with the murine target of teratogenic antibodies. Am. J. Pathol. 140, 33–44 (1992).

  42. 42.

    , , & Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissues. In Vivo 8, 343–351 (1994).

  43. 43.

    et al. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42, 531–542 (1994).

  44. 44.

    et al. Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc. Natl Acad. Sci. USA 84, 2990–2994 (1987).

  45. 45.

    , , & Expression of a cell surface antigen with potential Ca2+-sensor/receptor function in rat placenta and uterus. J. Reprod. Immunol. 16, 199–205 (1989).

  46. 46.

    et al. Ultrastructural localization of megalin in the rat cochlear duct. Hear. Res. 129, 83–91 (1999).

  47. 47.

    et al. Comparative immunochemistry and ontogeny of two closely related coated pit proteins. The 280-kd target of teratogenic antibodies and the 330-kd target of nephritogenic antibodies. Am. J. Pathol. 142, 1654–1667 (1993).

  48. 48.

    , , & Microdomains of distinctive glycoprotein composition in the kidney proximal tubule brush border. J. Cell Biol. 98, 1505–1513 (1984).

  49. 49.

    , , & Membrane receptors for endocytosis in the renal proximal tubule. Int. Rev. Cytol. 180, 237–284 (1998).

  50. 50.

    , , & 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J. 14, 2269–2280 (1995).This study and reference 52 establish RAP as a molecular chaperone for members of the LDLR family.

  51. 51.

    , & ERD2 proteins mediate ER retention of the HNEL signal of LRP's receptor-associated protein (RAP). J. Cell Sci. 110, 65–73 (1997).

  52. 52.

    , , & Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc. Natl Acad. Sci. USA 92, 4537–4541 (1995).

  53. 53.

    et al. RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J. 15, 2632–2639 (1996).

  54. 54.

    Receptor-associated protein (RAP): a specialized chaperone for endocytic receptors. Biol. Chem. 379, 1025–1031 (1998).

  55. 55.

    & Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein. J. Biol. Chem. 271, 22218–22224 (1996).

  56. 56.

    , , , & Receptor-associated protein is important for normal processing of megalin in kidney proximal tubules. J. Am. Soc. Nephrol. 11, 191–202 (2000).

  57. 57.

    , & Identification of apical sorting determinants in the cytoplasmic tail of megalin. J. Am. Soc. Nephrol. 12, Abstr. 60A–61A (2001).

  58. 58.

    , , , & Accurate and efficient cleavage of the human insulin proreceptor by the human proprotein-processing protease furin. Characterization and kinetic parameters using the purified, secreted soluble protease expressed by a recombinant baculovirus. J. Biol. Chem. 269, 25830–25837 (1994).

  59. 59.

    , , , & The low-density-lipoprotein receptor-related protein (LRP) is processed by furin in vivo and in vitro. Biochem. J. 313, 71–76 (1996).

  60. 60.

    , , , & Unusual processing of gp280, a protein associated with the intermicrovillar areas of yolk sac epithelial cells: plasma membrane delivery of immature protein. Biochem. Biophys. Res. Commun. 212, 353–359 (1995).

  61. 61.

    & Cubilin expression and posttranslational modification in the canine gastrointestinal tract. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G748–G756 (2000).

  62. 62.

    , , , & Defective brush-border expression of intrinsic factor–cobalamin receptor in canine inherited intestinal cobalamin malabsorption. J. Biol. Chem. 266, 4489–4494 (1991).

  63. 63.

    et al. Inherited selective intestinal cobalamin malabsorption and cobalamin deficiency in dogs. Pediatr. Res. 29, 24–31 (1991).

  64. 64.

    , , & Functional characterization of rat gp600/megalin promoter: combination of proximal Sp1 site and JCV repeat is important in rat gp600/megalin promoter activation. Gene 265, 123–131 (2001).

  65. 65.

    , , , & Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B100. J. Biol. Chem. 270, 19417–19421 (1995).

  66. 66.

    et al. Regulation of gp330/megalin expression by vitamins A and D. Eur. J. Clin. Invest. 28, 100–107 (1998).

  67. 67.

    et al. Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis. Proc. Natl Acad. Sci. USA 96, 10158–10163 (1999).This study, as well as reference 91, shows that apolipoprotein A1/HDL are ligands for cubilin, which indicates a role for cubilin in lipid metabolism

  68. 68.

    , & Transcription and translation of gp600 and receptor-associated protein (RAP) in active Heymann nephritis. Am. J. Pathol. 146, 1481–1487 (1995).

  69. 69.

    , , , & Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Aβ stabilization. J. Clin. Invest. 100, 310–320 (1997).

  70. 70.

    The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis. Curr. Opin. Nephrol. Hypertens. 7, 385–388 (1998).

  71. 71.

    , , , & CIC-5 Cl channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408, 369–373 (2000).

  72. 72.

    et al. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. Endocrinology 122, 2999–3001 (1988).

  73. 73.

    et al. Defective forebrain development in mice lacking gp330/megalin. Proc. Natl Acad. Sci. USA 93, 8460–8464 (1996).A report of targeted megalin gene knockout, which describes the megalin-deficient mouse phenotype.

  74. 74.

    et al. Megalin knockout mice as an animal model of low molecular weight proteinuria. Am. J. Pathol. 155, 1361–1370 (1999).

  75. 75.

    et al. Mutations in CUBN, encoding the intrinsic factor–vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. Nature Genet. 21, 309–313 (1999).This study links distinct mutations in the cubilin gene with hereditary megaloblastic anaemia I/ Imerslund–Gräsbecks disease in humans.

  76. 76.

    , , & Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins. J. Biol. Chem. 275, 12003–12008 (2000).

  77. 77.

    et al. Purified α2-macroglobulin receptor/LDL receptor-related protein binds urokinase–plasminogen activator inhibitor type-1 complex. Evidence that the α2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 267, 14543–14546 (1992).

  78. 78.

    , , & Specific association of megalin and the Na+/H+ exchanger isoform NHE3 in the proximal tubule. J. Biol. Chem. 274, 17518–17524 (1999).

  79. 79.

    et al. Evidence for an essential role of megalin in transepithelial transport of retinol. J. Am. Soc. Nephrol. 10, 685–695 (1999).

  80. 80.

    et al. Megalin is essential for renal proximal tubule reabsorption and accumulation of transcobalamin-B(12). Am. J. Physiol. Renal Physiol. 282, F408–F416 (2002).

  81. 81.

    et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96, 507–515 (1999).References 81 and 82 established the role of megalin and cubilin for the endocytosis of the carrier protein-bound steroid 25-OH–vitamin D3, and for the renal activation by hydroxylation of this vitamin.

  82. 82.

    et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25-(OH) vitamin D3. Proc. Natl Acad. Sci. USA 98, 13895–13900 (2001).

  83. 83.

    The free hormone hypothesis: a physiologically based mathematical model. Endocrinol. Rev. 10, 232–274 (1989).

  84. 84.

    et al. Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia. Proc. Natl Acad. Sci. USA 98, 12491–12496 (2001).

  85. 85.

    , , , & Uptake and processing of 59Fe-labelled and 125I-labelled rat transferrin by early organogenesis rat conceptuses in vitro. Placenta 18, 553–562 (1997).

  86. 86.

    et al. Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J. Am. Soc. Nephrol. 13, 423–430 (2002).

  87. 87.

    et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482–488 (1997).

  88. 88.

    Inhibition of endosome fusion in primary hepatocytes prevents asialoglycoprotein degradation but not uptake of transferrin iron demonstrating that intracellular iron release occurs from early endosomes. FEBS Lett. 466, 135–138 (2000).

  89. 89.

    & A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275, 19906–19912 (2000).

  90. 90.

    & The role of protein traffic in the progression of renal diseases. Annu. Rev. Med. 51, 315–327 (2000).

  91. 91.

    et al. The intrinsic factor–vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nature Med. 5, 656–661 (1999).

  92. 92.

    , , & Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J. Biol. Chem. 260, 744–750 (1985).

  93. 93.

    , , & Tissue sites of degradation of apoprotein A-I in the rat. J. Biol. Chem. 258, 7161–7167 (1983).

  94. 94.

    , , & Megalin (gp330): a putative endocytic receptor for thyroglobulin (Tg). Endocrinology 139, 1462–1465 (1998).

  95. 95.

    et al. Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release. J. Biol. Chem. 275, 7125–7137 (2000).This study shows that megalin in the thyrocyte is involved in regulated transcytosis of thyroglobulin. This was the first demonstration of megalin-mediated transcytosis.

  96. 96.

    & Role of thyroglobulin endocytic pathways in the control of thyroid hormone release. Am. J. Physiol. Cell Physiol. 279, C1295–C1306 (2000).

  97. 97.

    et al. Circulating thyroglobulin transcytosed by thyroid cells in complex with secretory components of its endocytic receptor megalin. J. Clin. Endocrinol. Metab. 85, 3458–3467 (2000).

  98. 98.

    et al. Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 84, 2468–2474 (1999).

  99. 99.

    et al. Megalin antagonizes activation of the parathyroid hormone receptor. J. Biol. Chem. 274, 5620–5625 (1999).

  100. 100.

    et al. A protein involved in calcium sensing of the human parathyroid and placental cytotrophoblast cells belongs to the LDL-receptor protein superfamily. Exp. Cell Res. 212, 344–350 (1994).

  101. 101.

    et al. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J. Clin. Invest. 96, 1404–1413 (1995).

  102. 102.

    et al. Megalin deficiency offers protection from renal aminoglycoside accumulation. J. Biol. Chem. 277, 618–622 (2002).

  103. 103.

    , & Cellular signalling by lipoprotein receptors. Curr. Opin. Lipidol. 11, 161–166 (2000).

  104. 104.

    , & Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin. Biochem. J. 347, 613–621 (2000).

  105. 105.

    , , & Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33556–33560 (1998).

  106. 106.

    et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689–701 (1999).

  107. 107.

    et al. Cubilin P1297L mutation associated with hereditary megaloblastic anemia 1 causes impaired recognition of intrinsic factor–vitamin B(12) by cubilin. Blood 96, 405–409 (2000).

  108. 108.

    & Role of rap in the biogenesis of lipoprotein receptors. Trends Cardiovasc. Med. 10, 148–155 (2000).

  109. 109.

    & Vitamin B12 transport by rat liver lysosomal membrane vesicles. J. Biol. Chem. 266, 9438–9441 (1991).

  110. 110.

    , , & Lysosomal cobalamin accumulation in fibroblasts from a patient with an inborn error of cobalamin metabolism (cblF complementation group): visualization by electron microscope radioautography. Exp. Cell Res. 195, 295–302 (1991).

  111. 111.

    Inhibition of endosome fusion in primary hepatocytes prevents asialoglycoprotein degradation but not uptake of transferrin iron demonstrating that intracellular iron release occurs from early endosomes. FEBS Lett. 466, 135–138 (2000).

  112. 112.

    , , & Transcytosis of retinol-binding protein across renal proximal tubule cells after megalin (gp 330)-mediated endocytosis. J. Am. Soc. Nephrol. 12, 637–648 (2001).

  113. 113.

    , , & Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am. J. Physiol. 271, F900–F907 (1996).

  114. 114.

    et al. Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. J. Clin. Invest. 105, 1353–1361 (2000).

  115. 115.

    , , , & Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267, 26172–26180 (1992).

  116. 116.

    et al. Evidence for the role of megalin in renal uptake of transthyretin. J. Biol. Chem. 275, 38176–38181 (2000).

  117. 117.

    et al. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270, 13070–13075 (1995).

  118. 118.

    et al. β2-glycoprotein-I (apolipoprotein H) and β2-glycoprotein-I–phospholipid complex harbor a recognition site for the endocytic receptor megalin. J. Clin. Invest. 102, 902–909 (1998).

  119. 119.

    et al. Megalin is an endocytic receptor for insulin. J. Am. Soc. Nephrol. 9, 1759–1766 (1998).

  120. 120.

    et al. Trichosanthin interacts with and enters cells via LDL receptor family members. Biochem. Biophys. Res. Commun. 270, 453–457 (2000).

  121. 121.

    et al. gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex. J. Cell Sci. 108, 2361–2368 (1995).

  122. 122.

    et al. Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator–plasminogen activator inhibitor type-1 complexes. J. Biol. Chem. 268, 16564–16570 (1993).

  123. 123.

    , , & Glycoprotein 330, a member of the low density lipoprotein receptor family, binds lipoprotein lipase in vitro. J. Biol. Chem. 268, 14176–14181 (1993).

  124. 124.

    & Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J. Biol. Chem. 266, 10825–10829 (1991).

  125. 125.

    et al. Monoclonal Gammapathies and the Kidney (eds Aucouturier, P., Hermine, P., Ronco, P. & Touchard, G.) (Klüwer, The Netherlands, 2002).

  126. 126.

    et al. Myeloma light chains are ligands for cubilin (gp280). Am. J. Physiol. 275, F246–F254 (1998).

  127. 127.

    et al. A two-receptor pathway for catabolism of Clara cell secretory protein in the kidney. J. Biol. Chem. 276, 13295–13301 (2001).

  128. 128.

    , , , & gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. Proc. Natl Acad. Sci. USA 89, 6698–6702 (1992).

  129. 129.

    , & The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, α2-macroglobulin receptor and glycoprotein 330. J. Biol. Chem. 267, 21162–21166 (1992).

  130. 130.

    & Analysis of a 45-kDa protein that binds to the Heymann nephritis autoantigen GP330. J. Biol. Chem. 268, 8188–8192 (1993).

  131. 131.

    , , , & Production of the nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc. Soc. Exp. Biol. Med. 100, 660–664 (1959).

  132. 132.

    , & Production of congenital malformations using tissue antibodies. I. Kidney antisera. Proc. Soc. Exp. Biol. Med. 106, 523–526 (1961).

Download references

Author information


  1. Department of Cell Biology, University of Aarhus, University Park, Building 234, DK-8000 Aarhus C, Denmark.;

    • Erik Ilsø Christensen
    •  & Henrik Birn


  1. Search for Erik Ilsø Christensen in:

  2. Search for Henrik Birn in:



A transmembrane receptor protein with the carboxyl terminus residing in the cytoplasm.


A stretch of 15–60 amino-acid residues, which direct the protein into, in this case, the endoplasmic reticulum.


The mammalian LDLR family consists of at least five membrane endocytic receptors, which share characteristic exodomain modules. The receptors mediate endocytic uptake of various ligands (for review, see Ref. 10).


Repeats with homology to sequences in the complement component 9. In the low-density lipoprotein receptors, these are arranged in clusters of 2–11 and constitute the ligand-binding regions. Each consists of about 40 amino acids with six cysteine residues.


Cysteine-rich repeats of about 50 amino acids, with sequence homology to epidermal growth factor.


An invagination of the plasma membrane, which is involved in receptor-mediated endocytosis. The cytoplasmic coat consists of adaptin and clathrin, which is involved in vesicle formation.


Proteins that are anchored to the non-cytoplasmic part of the membrane bilayer solely by a single molecule of glycosylphosphatidylinositol covalently linked lipid anchor added to the carboxyl terminus in the endoplasmic reticulum.


In part hydrophilic and in part hydrophobic.


The coupling, in this case, of palmitic acid to a cysteine residue in cubilin.


Stretches of amino acids that connect either β-sheets or α-helices in a protein.


The inner trophoblastic layer (see trophoectodermic cells) of cells that give rise to the syncytiotrophoblast facing the maternal circulation and constitute a layer through which all substances must pass from the mother to the fetus.


Epithelial cells that line the outer surface of the glomerular capillaries and constitute part of the glomerular filtration barrier.


Cells that line the alveolar walls of the lungs. These cells are involved in the production of surfactant (reducing surface tension and protecting the alveoli from collapsing during exhalation), and are responsible for proliferating and repopulating the alveolar lining of the lung.


The cells of the outer wall of the blastocyst that do not contribute to the formation of the embryo per se but finally develop into the fetal portion of the placenta.


The lumenal plasma membrane of specialized epithelial cells, which are characterized by closely aligned microvilli. These are characteristic of the proximal tubule of the kidney, the small intestine and other epithelia (see Fig. 4).


An endoplasmic reticulum (ER) retention signal that is similar to the sequence KDEL, which is required for the vesicular retrieval of ER-resident proteins from the Golgi network back to the ER. This is mediated by binding to specific receptors that are located in the Golgi network (also see Box 1).


Furin is a transmembrane serine protease, which is predominantly located in the trans-Golgi-network and immature secretory vesicles. It recognizes the RXXR sequence and cleaves a number of pro-proteins, including enzymes, hormones and receptors.


The human urinary excretion of more than 150 mg of protein in a 24-hour period.


From a general point of view, receptors that can bind and mediate the clearance of various ligands.


An inborn cranial defect, which is characterized by fusion of midline structures in the brain and face.


The absorptive epithelial cell of the intestine.


A metal-binding protein with a preference for ferric iron. Serum transferrin with a molecular weight of about 80 kDa transports iron from sites of absorption and storage to sites where it is used.


The hormone-producing cell of the thyroid gland. The cells synthesize thyroglobulin, which is secreted into a follicular lumen, iodinated, subsequently reabsorbed and then partly degraded in lysosomes to release the active thyroid hormones.


Transport of substances across epithelial cells, which involves endocytic internalization at one pole of the cell and exocytic release at another.


Drugs that have a net positive charge at neutral pH. Here, these include aminoglycoside antibiotics, polymyxin B and aprotinin.


Drugs that may damage the hearing and balance organs that are located in the inner ear, notably aminoglycoside antibiotics.

About this article

Publication history



Further reading